Cargando…
Cyclophosphamide/methylprednisolone/mycophenolate mofetil: COVID-19 and herpes zoster infection: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897136/ http://dx.doi.org/10.1007/s40278-022-10948-4 |
Ejemplares similares
-
Methylprednisolone/mycophenolate-mofetil/tacrolimus: COVID-19 Infection: case report
Publicado: (2022) -
Methylprednisolone/mycophenolate-mofetil/tacrolimus: COVID-19 pulmonary infection: case report
Publicado: (2021) -
Methylprednisolone/mycophenolate-mofetil/tacrolimus: COVID-19 pneumonia: case report
Publicado: (2020) -
Methylprednisolone/mycophenolate-mofetil/tacrolimus: COVID-19 pneumonia: case report
Publicado: (2021) -
Azathioprine/methylprednisolone/mycophenolate-mofetil: COVID-19 respiratory infection: 2 case reports
Publicado: (2021)